Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Azaya Therapeutics, Inc. Elects Ze’ev Shaked, Ph.D., to Board of Directors

Abstract:
Brings Track Record of Successful Product Commercialization

Azaya Therapeutics, Inc. Elects Ze’ev Shaked, Ph.D., to Board of Directors

SAN ANTONIO, TX | Posted on May 31st, 2007

Azaya Therapeutics, Inc. today announced the election of Dr. Ze'ev Shaked to its Board of Directors. Dr. Shaked has extensive managerial and pharmaceutical product development experience in commercializing new drug products. He most recently was President and CEO of Spherics, Inc., where he transformed the company into a product-driven company with an attractive product pipeline, and where he raised more than $25 million from the venture capital industry.

Prior to Spherics, Dr. Shaked was Chief Operating Officer of ILEX Oncology, Inc., in San Antonio, Texas. He was instrumental in ILEX obtaining ownership and FDA approval for CAMPATH and Clolar, two of its commercialized products. In addition, Dr. Shaked has held a number of senior research and development and corporate management positions at ImmuLogic Pharmaceutical Corporation, Berlex Biosciences, Inc., Triton Biosciences, Inc., CODON Corporation, and Chiron Corporation. He obtained his Ph.D. in Organic Chemistry and Applied Biochemistry from the Massachusetts Institute of Technology.

"Ze'ev Shaked has an outstanding track record in the biopharmaceutical industry and in overseeing the development of new drugs," said John Kerr, chairman of the board of Azaya. "His wealth of scientific experience will be invaluable in guiding the overall development of Azaya's pipeline of products."

####

About Azaya Therapeutics, Inc.
Azaya Therapeutics, Inc., is an emerging nanotherapy company with an innovative technology platform – Protein Stabilized Nanoparticles – (PSNTM) designed to significantly improve the efficacy and safety of water insoluble pharmaceutical agents. Azaya is initially building an in-house pipeline of safer and more efficacious nanoparticle chemotherapy drug products. Azaya was granted a patent on this technology in February 2007.

For more information, please click here

Contacts:
Azaya Therapeutics, San Antonio
Michael T. Dwyer, 210-341-6600
or
Dublin & Associates
Eric Whittington, 210-227-0221, ext. 239

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Gold-diamond nanodevice for hyperlocalised cancer therapy: Gold nanorods can be used as remote controlled nanoheaters delivering the right amount of thermal treatment to cancer cells, thanks to diamond nanocrystals used as temperature sensors August 1st, 2015

Heating and cooling with light leads to ultrafast DNA diagnostics July 31st, 2015

Take a trip through the brain July 30th, 2015

Sol-gel capacitor dielectric offers record-high energy storage July 30th, 2015

Announcements

Thin films offer promise for ferroelectric devices: Researchers at Tokyo Institute of Technology demystify the ferroelectric properties observed in hafnium-oxide-based thin films, revealing a potentially useful device material August 3rd, 2015

Transparent, electrically conductive network of encapsulated silver nanowires: A novel electrode for optoelectronics August 1st, 2015

Harris & Harris Group Portfolio Company, HZO, Announces Partnerships with Dell and Motorola August 1st, 2015

Advances and Applications in Biosensing, Sensor Power, and Sensor R&D to be Covered at Sensors Global Summit August 1st, 2015

Appointments/Promotions/New hires/Resignations/Deaths

Kalam: versatility personified August 1st, 2015

The National Space Society Pays Tribute to Dr. Kalam -- One Of Our Leading Lights Has Joined The Stars August 1st, 2015

American Chemical Society expands reach to include rapidly emerging area of sensor science July 25th, 2015

BESSTECH Names Doug Grose as Chief Technology Officer: Former GLOBALFOUNDRIES CEO to drive technology roadmap and strategic partnerships for emerging lithium-ion battery component company July 14th, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project